key: cord-1032546-frqwvmuf authors: Ridwan, Khalid; DeVarennes, Benoit; Tchervenkov, Christo; Shum-Tim, Dominique; Cecere, Renzo; Lachapelle, Dr. Kevin title: Postoperative Nosocomial COVID 19 infection in Cardiac Surgery: An Uncommon event with High Mortality date: 2021-06-05 journal: CJC Open DOI: 10.1016/j.cjco.2021.05.017 sha: e8539d8592a45371c412b5d7da3dc52a485f5c4c doc_id: 1032546 cord_uid: frqwvmuf The COVID-19 pandemic has had a major impact on cardiac surgery patients. Significant reductions in access to surgical treatment have forced surgeons to prioritise patients and follow strict COVID-19 protocols to protect surgeons, staff, and patients.(1) Nosocomial infections among Cardiac Surgery patients have been reported and are associated with a high mortality.(2) As a COVID-19 tertiary care centre and a tertiary cardiac centre, we tried to balance the need to operate on urgent cardiac cases while protecting patients and staff from COVID-19. During the first wave of the pandemic, a total of 579 surgeries were performed. We report findings from an outbreak of four nosocomial infections. All patients tested negative within 24 hours of surgery or admission. Three patients were positive following surgery, suggesting an overall nosocomial rate during the first wave of 0.5% (3/579). One patient admitted for evaluation tested positive during mass screening. Two of the four patients died following respiratory complications. No healthcare worker (HCW) or family member with direct contact with these patients tested positive for COVID-19. Nosocomial COVID-19 infection is uncommon when adhering to safety protocols. Although uncommon, the mortality rate is high (50%) in our series. As widespread vaccination of HCWs and high-risk individuals susceptible to COVID-19 is in progress, we suggest that cardiac surgery patients, when feasible, be vaccinated prior to surgery given this could prevent excess mortality, protect HCWs and reduce resource use. The COVID-19 pandemic has had a major impact on cardiac surgery patients. Access to surgical care has been limited or reduced. Moreover, it presents a significant risk for hospitalized patients following surgery. Nosocomial infection with COVID-19 has been reported and is associated with a high mortality. We report findings of four nosocomial infections in cardiac surgery patients. The COVID-19 pandemic has had a major impact on cardiac surgery patients. Significant reductions in access to surgical treatment have forced surgeons to prioritise patients and follow strict COVID-19 protocols to protect surgeons, staff, and patients. 1 Nosocomial infections among Cardiac Surgery patients have been reported and are associated with a high mortality. 2 As a COVID-19 tertiary care centre and a tertiary cardiac centre, we tried to balance the need to operate on urgent cardiac cases while protecting patients and staff from COVID-19. During the first wave of the pandemic, a total of 579 surgeries were performed. We report findings from an outbreak of four nosocomial infections. All patients tested negative within 24 hours of surgery or admission. Three patients were positive following surgery, suggesting an overall nosocomial rate during the first wave of 0.5% (3/579). One patient admitted for evaluation tested positive during mass screening. Two of the four patients died following respiratory complications. No Since the World Health Organization (WHO) declared COVID-19 to be a global pandemic in March 2020, there have been more than 100 million confirmed cases with over 2.5 million fatalities due to COVID-19 around the world. Due to increased demand for ICU beds and healthcare resources, most cardiac surgery centres have had to adjust their case volumes during the first wave to liberate resources to care for COVID-19 patients. The Canadian Society of Cardiac Surgeons has been actively involved in providing guidance for the safety of both patients and medical personnel and providing effective methods to prioritize and follow up pre-operative patients to mitigate the risk of protracted waiting times. 3 However, it is clear that a balance is required between the need to treat COVID-19 and the need to treat cardiac patients while ensuring patient's and HCW's safety. In small case series, the rate of nosocomial COVID-19 infection among cardiac surgery patients is deemed to be low but it is reported to have a high mortality rate of up to 43%. 2 Herein, we report findings from an outbreak of four nosocomial infections among cardiac surgery patients during the first wave in a tertiary care hospital which is also heavily involved in the treatment of COVID-19 patients. The first wave was defined to occur from March 16 th to December 10 th , 2020. This period essentially reflects the impact on Cardiac surgery cases starting with a significant reduction then a gradual increase to normal volumes to the start of another period of reduced activity. Preoperatively, all patients are carefully screened with a detailed history, physical exam, Chest Operating room protocols are enforced and have been previously described. 5 All healthcare professionals, patients, and visitors wear a mask with application of hand hygiene, appropriate donning and doffing of personal protective equipment for contact-droplet precautions and aerosol protection when indicated. Nosocomial infections are defined as patients that contracted the disease in the hospital and were symptomatic or tested positive 14 days after admission. Those who tested positive after 5 days from admission and had no presenting symptoms, are considered probable nosocomial infections as it is also possible that they had a latent period of a community acquired infection. During this period, we performed 579 cardiac surgery cases, representing 78% of our normal capacity. Three patients tested positive for COVID-19 after surgery, while a fourth patient with an LVAD tested positive as part of mass screening after being transferred to our centre from another hospital for management of a GI bleed. All patients tested positive within three days of each other. The ward was quarantined, contact-droplet precautions were applied to all patients and mass screening was performed for all HCWs, patients and family members every 5 days until 14 days of the last exposure. Two HCWs tested positive but were not directly involved in care of the positive patients. Two patients died from respiratory failure related to COVID-19, whereas another patient recovered from the respiratory infection albeit he suffered wound dehiscence and mediastinitis after starting Steroids for his COVID-19 pneumonia. One patient was essentially asymptomatic. to the COVID unit for 6 days and started treatment with Dexamethasone and IV antibiotics before being transferred to the ICU for severe dyspnea and increased oxygen requirement. He was eventually intubated and developed acute renal failure then passed away after 10 days in the ICU from respiratory failure. A 57 year old male with hypertension, diabetes mellitus II, previous ischemic stroke who presented with acute congestive heart failure. He was found to have multivessel coronary artery disease with severe mitral regurgitation, he underwent CABGx5 and mitral valve repair . The ICU course was uncomplicated and was transferred to the floor on POD 3. While on the floor he developed fever and tested negative, he was swabbed again following persistent fever and tested positive for COVID-19 on POD 16. He was admitted to the COVID unit on minimal oxygen support and was treated with dexamethasone, he was transferred back to the cardiac surgery floor after he recovered from his COVID-19 pneumonia. He developed a sternal wound infection that required treatment with IV antibiotics and a Pectoral flap. He was discharged after spending 52 days at the hospital. A 75 year old male with a previous LVAD surgery in 2015 All three post-operative patients were waiting for transfer to a Rehab Centre when tested positive and had a subsequent prolonged hospital stay. hospital, especially those subjected to cardiac surgery given that surgery may induce both an inflammatory and immunocompromised state. Our experience during the first wave of the pandemic demonstrates that the risk of transmission is low even in a tertiary hospital at the centre of the pandemic. Our case volume slowly improved following a near 4 weeks shut down starting on March 16 th. , and were fully functional until the start of the second wave. During this time, we were able to perform 579 cases which represents 78% of our normal volume. An outbreak occurred on the ward which infected 4 patients, 3 of which were waiting for discharge 12-19 days after surgery. Unfortunately, 2 patients died after a prolonged ICU stay. No doubt that the application and adherence of strict COVID-19 policies and procedures had a beneficial effect in limiting the number of nosocomial infections and outbreaks. Furthermore, we had no other incidents of outbreaks or any further nosocomial infections to date. Unfortunately, since nearly all HCWs, patients, and families tested negative for COVID-19, the source of the outbreak is not known. This underlines the necessity to continue to adhere to COVID-19 guidelines and to remain vigilant. Testing must be done post-operatively to rule out COVID-19 when the clinical situation is appropriate. Given the low rate of nosocomial infection, patients should have some reassurance that they are relatively safe from COVID-19 and life-saving procedures should take precedence over fear of contracting COVID. However, we were fortunate in that our outbreak was limited. The situation could have been much worse with a potential of infecting more than 30 patients on the ward not to mention over 100 HCWs. Given the high mortality and high resource use in COVID-19 patients, this could have been a catastrophe for patients and the hospital. Since we are unsure how the outbreak started in the first place, the best approach would be to maximize prevention. Strict adherence to COVID-19 policies continues to be essential, and as was seen with the LVAD patient, asymptomatic infections can be encountered in the cardiac surgery unit. Proper practice of personal protection equipment (PPE) and mass screening helped diminish the risk of such asymptomatic patient from spreading the infection and becoming a source of another outbreak. Moreover, LVAD patients presents a special subset of cardiac surgery patients in which their hospital re-admission rates are higher than other cardiac surgical patients and they require frequent outpatient follow up. This makes them more liable to get infected and thus should be treated diligently with applications of PPEs when being seen in the clinic or in the in-hospital setting. Furthermore, they should be encouraged to get vaccinated to help reduce this risk and allow for safer care in the ward or the clinic. Rapid discharge from hospital would also seem to be appropriate as three of these patients were waiting in hospital as a consequence of reduced convalescence beds, even though there have been reports of outbreaks in long term care facilities at the beginning of the pandemic. These were attributed to poor adherence to contact precautions and lack of widespread testing. Increased awareness, better preparations and strictly admitting patients that test negative for COVID-19 in these centres make them a viable option for patients that can't be discharged home, particularly when they are hospitalized in a referral centre dealing with COVID-19 patients. With the availability of vaccinations, they can be immunized after surgery prior to being transferred. The results of our case series can be limited due to several reasons such as the small number of Lastly, our cohort consisted of non-vaccinated patients and the majority of HCWs were not vaccinated at that time. Vaccination prior to surgery could be an important component in limiting deadly outbreaks and infection. Many cardiac surgery patients can wait two weeks to allow for vaccination. As the roll out starts, cardiac patients should be prioritized for vaccination, not only for their safety but also for the safety of the hospital and staff. Adult cardiac surgery and the COVID-19 pandemic: Aggressive infection mitigation strategies are necessary in the operating room and surgical recovery Outcomes of patients diagnosed with COVID-19 in the early postoperative period following cardiac surgery Ramping Up the Delivery of Cardiac Surgery During the COVID-19 Pandemic: A Guidance Statement From the Canadian Society of Cardiac Surgeons The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application Best practice in cardiac anesthesia during the COVID-19 pandemic: Practical recommendations COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment McGill University Health Centre None National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/.